IL-25 induces both inflammation and skin barrier dysfunction in atopic dermatitis

Chemical Immunology and Allergy

Volumn 96, Issue , 2012, Pages 45-49

  Deleuran, Mette ^a   Hvid, Malene ^b   Kemp, Kaare ^c   Christensen, Gitte B ^c   Deleuran, Bent ^b   Vestergaard, Christian ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c LEO PHARMA A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 25; MESSENGER RNA; FILAGGRIN;

ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DERMIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; SKIN INFLAMMATION; ARTICLE; BASEMENT MEMBRANE; CELL STRUCTURE; CELLULAR IMMUNITY; INFLAMMATION; MESSENGER RNA SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; SKIN BARRIER DYSFUNCTION; SKIN DISEASE; TH2 CELL;

DENDRITIC CELLS; DERMATITIS, ATOPIC; HUMANS; INFLAMMATION; INTERLEUKIN-17; INTERMEDIATE FILAMENT PROTEINS; KERATINOCYTES; SKIN;

EID: 84859169862     PISSN: 16602242     EISSN: 16622898     Source Type: Book Series    
DOI: 10.1159/000331871     Document Type: Review

References (10)

1. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38:441-446.
2. Rickel EA, Siegel LA, Yoon BR, Rottman JB, Kugler DG, Swart DA, Anders PM, Tocker JE, Comeau MR, Budelsky AL: Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol 2008;181:4299-4310.
3. Lee J, Ho WH, Maruoka M, Corpuz RT, Baldwin DT, Foster JS, Goddard AD, Yansura DG, Vandlen RL, Wood WI, Gurney AL: IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 2001;276:1660-1664.
4. Hurst SD, Muchamuel T, Gorman DM, Gilbert JM, Clifford T, Kwan S, Menon S, Seymour B, Jackson C, Kung TT, Brieland JK, Zurawski SM, Chapman RW, Zurawski G, Coffman RL: New IL-17 family members promote Th1 or Th2 responses in the lung: In vivo function of the novel cytokine IL-25. J Immunol 2002;169:443-453.
5. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R, Muchamuel T, Hurst SD, Zurawski G, Leach MW, Gorman DM, Rennick DM: IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001;15:985-995.
6. Angkasekwinai P, Park H, Wang YH, Wang YH, Chang SH, Corry DB, Liu YJ, Zhu Z, Dong C: Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007;204:1509-1517.
7. Ikeda K, Nakajima H, Suzuki K, Kagami S, Hirose K, Suto A, Saito Y, Iwamoto I: Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation. Blood 2003;101:3594-3596.
8. Wang YH, Angkasekwinai P, Lu N, Voo KS, Arima K, Hanabuchi S, Hippe A, Corrigan CJ, Dong C, Homey B, Yao Z, Ying S, Huston DP, Liu YJ: IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007;204:1837-1847.
9. Hvid M, Vestergaard C, Kemp K, Christensen GB, Deleuran B, Deleuran M: IL-25 in atopic dermatitis: A possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 2011;131:150-157.
10. Kristensen MS, Paludan K, Larsen CG, Zachariae CO, Deleuran BW, Jensen PK, Jørgensen P, Thestrup-Pedersen K: Quantitative determination of IL-1 alpha-induced IL-8 mRNA levels in cultured human keratinocytes, dermal fibroblasts, endothelial cells, and monocytes. J Invest Dermatol 1991;97: 506-510.